Literature DB >> 5658870

Renal clearance of oxipurinol, the chief metabolite of allopurinol.

G B Elion, T F Yü, A B Gutman, G H Hitchings.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5658870     DOI： 10.1016/0002-9343(68)90008-9

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  44 in total

1.  The pharmacokinetics of oxypurinol in people with gout.

Authors:  Sophie L Stocker; Andrew J McLachlan; Radojka M Savic; Carl M Kirkpatrick; Garry G Graham; Kenneth M Williams; Richard O Day
Journal:  Br J Clin Pharmacol       Date:  2012-09       Impact factor: 4.335

Review 2.  Effect of dietary protein on renal tubular clearance of drugs in humans.

Authors:  G D Park; R Spector; T M Kitt
Journal:  Clin Pharmacokinet       Date:  1989-12       Impact factor: 6.447

3.  Nobel lecture in physiology or medicine--1988. The purine path to chemotherapy.

Authors:  G B Elion
Journal:  In Vitro Cell Dev Biol       Date:  1989-04

4.  Allopurinol-hypersensitivity vasculitis and liver damage.

Authors:  T D Boyer; N Sun; T B Reynolds
Journal:  West J Med       Date:  1977-02

5.  Reply to "Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!" by Stamp et al.

Authors:  Solène M Laville; Bénédicte Stengel; Ziad A Massy; Sophie Liabeuf
Journal:  Br J Clin Pharmacol       Date:  2019-04-13       Impact factor: 4.335

6.  Understanding the dose-response relationship of allopurinol: predicting the optimal dosage.

Authors:  Garry G Graham; Diluk R W Kannangara; Sophie L Stocker; Ian Portek; Kevin D Pile; Praveen L Indraratna; Indira Datta; Kenneth M Williams; Richard O Day
Journal:  Br J Clin Pharmacol       Date:  2013-12       Impact factor: 4.335

7.  Effects of topiroxostat in hyperuricemic patients with chronic kidney disease.

Authors:  Taro Horino; Yutaka Hatakeyama; Osamu Ichii; Tatsuki Matsumoto; Yoshiko Shimamura; Kosuke Inoue; Yoshio Terada; Yoshiyasu Okuhara
Journal:  Clin Exp Nephrol       Date:  2017-07-27       Impact factor: 2.801

Review 8.  Clinical pharmacokinetics of allopurinol.

Authors:  G A Murrell; W G Rapeport
Journal:  Clin Pharmacokinet       Date:  1986 Sep-Oct       Impact factor: 6.447

Review 9.  Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure.

Authors:  D E Drayer
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

10.  Effects of pyrazinamide, probenecid, and benzbromarone on renal excretion of oxypurinol.

Authors:  T Yamamoto; Y Moriwaki; S Takahashi; M Suda; K Higashino
Journal:  Ann Rheum Dis       Date:  1991-09       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.